2560 General Armistead Ave
Audubon, Pennsylvania 19403-5214
GMED earnings call for the period ending December 31, 2022.
Globus Medical, Inc. (NYSE:NYSE:GMED) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ETCompany ParticipantsBrian Kearns - Senior Vice President of Business Development and…
Globus Medical press release (GMED): Q4 Non-GAAP EPS of $0.59 beats by $0.03.Revenue of $274.5M (+9.8% Y/Y) misses by $1.9M.,The Company today announced full year stand-alone…
AUDUBON, Pa., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2022.
Globus Medical (GMED) is scheduled to announce Q4 earnings results on Tuesday, February 21st, after market close.The consensus EPS Estimate is $0.56 (+14.3% Y/Y) and the consensus…
Globus Medical (NYSE: GMED ) is set to give its latest quarterly earnings report on Tuesday, 2023-02-21. Here''s what investors need to know before the announcement. Analysts estimate that Globus Medical will report an earnings per share (EPS) of $0.56. Globus Medical bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the … Full story available on Benzinga.com
Globus Medical Inc. (NYSE:GMED) traded at $59.43 at close of the session on Monday, 02/13/23, made a downward move of -1.41% on its previous day’s price. Looking at the stock we see that its previous close was $60.28 and the beta (5Y monthly) reads 1.04 with the day’s price range being $58.98 – $60.55. The … Globus Medical Inc. (NYSE: GMED) -1.41% Decline Turns Investors Off From Company Stock Read More »
Globus Medical announced a merger with NuVasive on February 8. Find out should the retail investors of GMED and NUVA buy, hold, or sell their shares.
Globus Medical is a producer of musculoskeletal implants used for patients who suffer from spine disorders. Click here to read my analysis of GMED stock.
Globus and NuVasive''s merger deal will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share. Read what investors need to know.
Currently, Globus Medical Inc.’s (GMED) stock is trading at $61.06, marking a fall of -3.03% from last night’s close. At this price, the stock is -25.34% below its 52-week high of $81.78 and 16.08% above its 52-week low of $52.60. Based on the past 30-day period, the stock price is -24.34% below the high and […]
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post That Will Motivate You Today: Warner Bros. Discovery, Inc. (NASDAQ:WBD -1.30%), Globus Medical, Inc. (NYSE:GMED -18.18%) appeared first on Stocks Equity .
Companies contend there is little overlap, which opens the door for cross-selling products and services in the competitive spine surgery technology market.
Globus Medical(GMED.US)拟以30亿美元收购纽瓦索器材(NUVA.US) 股价暴跌18%
Globus Medical Inc said on Thursday it would acquire peer NuVasive Inc in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices. NuVasive shareholders will receive 0.75 of Globus shares, implying a per-share offer of $57.72 and a premium of about 26% to Wednesday’s close. Shares […]
Globus Medical Inc said on Thursday it would acquire peer NuVasive Inc in an all-stock deal valued at about $3 billion to build scale in the competitive market for spinal devices.
MILWAUKEE, Feb. 9, 2023 /PRNewswire/ -- Ademi LLP is investigating NuVasive (NASDAQ: NUVA) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical. Click here to learn how to join the action https://www.ademilaw.com/case/nuvasive-inc or…
Globus Medical (GMED) was cut to neutral from overweight at Piper Sandler after agreeing to acquire Nuvasive Medical in more than $3 billion all stock deal
Shares of medical devices provider Globus Medical (NYSE:GMED) are tanking today after the company announced an all-stock combination with NuVasive …
Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc., Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical.
AUDUBON, Pa., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year ended December 31, 2022 after the market close on Tuesday, February 21, 2023. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com .